• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国的肺泡型棘球蚴病。

Alveolar echinococcosis in China.

作者信息

Jiang C

机构信息

Hydatidosis Research Laboratory, Lanzhou Medical College, China.

出版信息

Chin Med J (Engl). 1998 May;111(5):470-5.

PMID:10374362
Abstract

DATA SOURCES

All reference data originated from related Chinese- or English-language literature in Chinese journals.

STUDY SELECTION

Twenty-three original articles published in 1992-1996 were selected according to the stated purpose and 9 of them were written by myself.

DATA EXTRACTION

The present paper dealt with 5 subtopics, i.e. epidemiology, parasitology, pathology, diagnosis, treatment and prognosis.

RESULTS

Five hundred and eighty-four patients with alveolar echinococcosis (AE) have been reported from 7 provinces or autonomous regions. Human infection rate was 19.2% or 2.8%, and the morbidity was 2.4%-5.0%. The intermediate hosts of Echinococcus multilocularis included 7 species of rodents and 3 species of livestocks, and the final hosts of that were fox, dog or wolf. Diagnosis of AE was chiefly based on imaging examination (ultrasound and CT) and immunological test. The operative resection rate for liver AE was only 10.5% (27/258). Albendazole was a certain remedy for the chemotherapy of AE, and TCM "Xiao-Bao" pill may be a hopeful drug.

CONCLUSIONS

In the past 30 years, a lot of work concerning basic and clinical studies has been done in China and some achievements have been achieved. However, some important problems such as how to conduct further research on molecular biology, how to make early diagnosis, how to improve the chemotherapeutic effect, and how to control the prevalence of AE, need to be studied more deeply in the 21st century.

摘要

资料来源

所有参考文献数据均源自中国期刊上的相关中英文文献。

研究选择

根据既定目的选取了1992 - 1996年发表的23篇原创文章,其中9篇为本人撰写。

资料提取

本文涉及5个主题,即流行病学、寄生虫学、病理学、诊断、治疗与预后。

结果

7个省或自治区共报告了584例肺泡型棘球蚴病(AE)患者。人群感染率为19.2%或2.8%,发病率为2.4% - 5.0%。多房棘球绦虫的中间宿主包括7种啮齿动物和3种家畜,终末宿主为狐狸、狗或狼。AE的诊断主要基于影像学检查(超声和CT)及免疫学检测。肝AE的手术切除率仅为10.5%(27/258)。阿苯达唑是AE化疗的一种有效药物,中药“消包”丸可能是一种有希望的药物。

结论

在过去30年里,中国在基础和临床研究方面做了大量工作并取得了一些成果。然而,一些重要问题,如如何在分子生物学方面开展进一步研究、如何进行早期诊断、如何提高化疗效果以及如何控制AE的流行,在21世纪仍需更深入地研究。

相似文献

1
Alveolar echinococcosis in China.中国的肺泡型棘球蚴病。
Chin Med J (Engl). 1998 May;111(5):470-5.
2
Epidemiology of alveolar echinococcosis with particular reference to China and Europe.肺泡型棘球蚴病的流行病学,特别关注中国和欧洲
Parasitology. 2003;127 Suppl:S87-107.
3
Today's regional distribution of echinococcosis in China.中国当今棘球蚴病的地区分布情况。
Chin Med J (Engl). 2002 Aug;115(8):1244-7.
4
Epidemiology of human alveolar echinococcosis in China.中国人体肺泡型棘球蚴病的流行病学
Parasitol Int. 2006;55 Suppl:S221-5. doi: 10.1016/j.parint.2005.11.034. Epub 2005 Dec 9.
5
A historical view of alveolar echinococcosis, 160 years after the discovery of the first case in humans: part 1. What have we learnt on the distribution of the disease and on its parasitic agent?回顾 160 年前首例人类泡型包虫病发现以来的历史:第 1 部分。我们在疾病分布及其寄生虫方面有哪些了解?
Chin Med J (Engl). 2011 Sep;124(18):2943-53.
6
Usefulness of recombinant Em18-ELISA to evaluate efficacy of treatment in patients with alveolar echinococcosis.重组Em18-ELISA在评估肺泡型棘球蚴病患者治疗效果中的应用价值。
J Gastroenterol. 2005 Apr;40(4):426-31. doi: 10.1007/s00535-004-1559-7.
7
Epidemiological progresses of hemorrhagic fever with renal syndrome in China.中国肾综合征出血热的流行病学进展
Chin Med J (Engl). 1999 May;112(5):472-7.
8
Perspective on control options for Echinococcus multilocularis with particular reference to Japan.多房棘球绦虫防控措施的展望,特别提及日本
Parasitology. 2003;127 Suppl:S159-72.
9
Human alveolar echinococcosis in Slovenia.斯洛文尼亚的人体肺泡型棘球蚴病。
Clin Microbiol Infect. 2007 May;13(5):544-6. doi: 10.1111/j.1469-0691.2007.01701.x. Epub 2007 Mar 19.
10
Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans.《包虫病(棘球蚴病、包虫病)临床诊断与治疗专家共识(2023 版)》
Acta Trop. 2010 Apr;114(1):1-16. doi: 10.1016/j.actatropica.2009.11.001. Epub 2009 Nov 30.

引用本文的文献

1
Advances in the pharmacological treatment of hepatic alveolar echinococcosis: From laboratory to clinic.肝泡型包虫病药物治疗的进展:从实验室到临床
Front Microbiol. 2022 Aug 8;13:953846. doi: 10.3389/fmicb.2022.953846. eCollection 2022.
2
Evaluation of intrahepatic manifestation and distant extrahepatic disease in alveolar echinococcosis.评估泡型包虫病的肝内表现和肝外远处疾病。
World J Gastroenterol. 2020 Aug 7;26(29):4302-4315. doi: 10.3748/wjg.v26.i29.4302.
3
Difficulties in the diagnosis and management of alveolar hydatid disease: A case series.
肺泡型包虫病的诊断与治疗难点:病例系列报道
Caspian J Intern Med. 2016 Winter;7(1):52-6.
4
Metastatic and prognostic factors in patients with alveolar echinococcosis.肺泡型棘球蚴病患者的转移和预后因素
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11192-8. eCollection 2015.
5
Case studies emphasising the difficulties in the diagnosis and management of alveolar echinococcosis in rural China.强调在中国农村诊断和治疗泡型包虫病困难的病例研究。
Parasit Vectors. 2011 Oct 9;4:196. doi: 10.1186/1756-3305-4-196.
6
Palliative operation for the treatment of alveolar echinococcosis.用于治疗肺泡型棘球蚴病的姑息性手术。
Langenbecks Arch Surg. 2009 Jan;394(1):199-204. doi: 10.1007/s00423-008-0367-6. Epub 2008 Jun 25.
7
Alveolar echinococcosis of the liver in a Tokyo resident with an unknown route of infection: report of a case.一名感染途径不明的东京居民的肝泡型包虫病:病例报告
Surg Today. 2006;36(8):750-3. doi: 10.1007/s00595-004-3241-3.
8
Echinococcosis in Tibetan populations, western Sichuan Province, China.中国四川省西部藏族人群中的棘球蚴病
Emerg Infect Dis. 2005 Dec;11(12):1866-73. doi: 10.3201/eid1112.050079.
9
Liver alveolar echinococcosis in China: clinical aspect with relative basic research.中国肝脏泡型包虫病:临床情况与相关基础研究
World J Gastroenterol. 2005 Aug 14;11(30):4611-7. doi: 10.3748/wjg.v11.i30.4611.